Bancel Stephane's Form 4 filing
Moderna, Inc. (MRNA) · filed Aug 7, 2026
- Accession no.
- 0001682852-26-000153
- Filed
- Aug 7, 2026, 4:11 PM ET
- Trade date
- Aug 5-6, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $28.7M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bancel StephaneCIK 0001443340 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Common Stock | MOption exerciseAcquired | +499,246 | $19.15 | +$9,560,560.9 | 6,687,037 | Direct | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −147,473 | $56.21F2 | −$8,289,457.33 | 6,539,564 | Direct | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −124,838 | $56.96F3 | −$7,110,772.48 | 6,414,726 | Direct | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −39,891 | $58.12F4 | −$2,318,464.92 | 6,374,835 | Direct | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −187,044 | $58.79F5 | −$10,996,316.76 | 6,187,791 | Direct | |
| Aug 6, 2026 | Common Stock | MOption exerciseAcquired | +252,469 | $19.15 | +$4,834,781.35 | 6,440,260 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Common Stock | MOption exerciseDisposed | −370,853 | $0.00 | $0 | 187,541 | Direct | |
| Aug 5, 2026 | Common Stock | MOption exerciseDisposed | −128,393 | $0.00 | $0 | 64,928 | Direct | |
| Aug 6, 2026 | Common Stock | MOption exerciseDisposed | −187,541 | $0.00 | $0 | 0 | Direct | |
| Aug 6, 2026 | Common Stock | MOption exerciseDisposed | −64,928 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.58 to $56.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.59 to $57.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.60 to $58.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.61 to $59.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.